Medications to treat type-2 diabetes such as Ozempic and Semaglutide have a secondary use as rapid weight loss medications. It is so popular among...
Vous n'êtes pas connecté
CNN — People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say it shouldn’t deter patients from using the medicines to treat diabetes or obesity. Last summer, doctors at Mass Eye and Ear noticed an unusually high number of patients …
Medications to treat type-2 diabetes such as Ozempic and Semaglutide have a secondary use as rapid weight loss medications. It is so popular among...
WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study...
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...
Weight loss jabs Ozempic and Wegovy could raise the risk of going blind, research suggests.
TUESDAY, July 2, 2024 -- Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide...
GENEVA, Switzerland – The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are...
There are no current treatments for non-arteritic anterior ischemic optic neuropathy (NAION) and vision often does not improve.
TUESDAY, June 24, 2024 -- Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women...
A line of frozen pizza and protein-enriched pasta dishes will be launched by Nestle in the USA, specifically aimed at taking weight loss drugs such as...
Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy